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Pseudomonas aeruginosa is an opportunistic pathogen that causes infections mainly
in patients with cystic fibrosis (CF) lung disease. Despite innate and adaptive immune
responses upon infection, P. aeruginosa is capable of efficiently escaping host defenses,
but the underlying immune mechanisms remain poorly understood. Myeloid-derived
suppressor cells (MDSCs) are innate immune cells that are functionally characterized by
their potential to suppress T- and natural killer (NK)-cell responses. Here we demonstrate,
using an airway in vivo infection model, that P. aeruginosa recruits and activates
neutrophilic MDSCs, which functionally suppress T-cell responses. We further show that
the CF gene defect (CF transmembrane conductance regulator, CFTR) modulates the
functionality, but not the recruitment or generation of neutrophilic MDSCs. Collectively, we
define a mechanism by which P. aeruginosa airway infection undermines host immunity
by modulating neutrophilic MDSCs in vivo.
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INTRODUCTION
Infections with Pseudomonas aeruginosa, an opportunistic gram-negative bacterium, represent
a major cause of morbidity and mortality in patients with cystic fibrosis (CF) lung disease,
chronic obstructive pulmonary disease (COPD), ventilated patients, and patients undergoing
immunosuppression (Williams et al., 2010; Hartl et al., 2012). Upon infection, P. aeruginosa
activates the innate immune system and induces a rapid recruitment of neutrophilic cells to
the site of inflammation, followed by activation of the adaptive response characterized by T-cell
infiltration (Hartl et al., 2012). Despite a substantial and sustained presence of phagocytic and
lymphocytic immune cells at the infected compartment, the host is not able to efficiently eliminate
P. aeruginosa, particularly in pulmonary disease conditions, such as CF (caused by mutations in the
CF transmembrane conductance regulator, CFTR, gene) or chronic obstructive pulmonary disease
(COPD, caused by cigarette smoke; Hartl et al., 2012; Mall and Hartl, 2014; Yonker et al., 2015).
The underlying immune mechanisms remained poorly understood.
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Myeloid-derived suppressor cells (MDSCs) are innate
immune cells that are functionally characterized by their
potential to suppress T- and natural killer (NK)-cell responses
(Gabrilovich and Nagaraj, 2009; Gantt et al., 2014). MDSCs
can be sub-divided into neutrophilic and monocytic MDSCs as
defined by surface marker profiles. Rieber et al. demonstrated in
a previous study that neutrophilic MDSCs accumulate in patients
with CF infected with P. aeruginosa (Rieber et al., 2013). We
further showed that neutrophilic MDSCs are clinically relevant
in P. aeruginosa infected CF patients, because percentages of
neutrophilic MDSCs correlated with lung function in those
patients. However, the mechanisms by which P. aeruginosa
airway infection regulates neutrophilic MDSCs in vivo remained
elusive.
Here, we used a well-established P. aeruginosa airway
infection model (Munder and Tummler, 2014; Hector et al.,
2015) to investigate the mechanisms by which P. aeruginosa
skews host immunity in vivo. Our studies demonstrate that
(i) P. aeruginosa airway infection triggers the recruitment of
neutrophilic, but not monocytic MDSCs, (ii) P. aeruginosa
infection enhances the suppressive capacity of neutrophilic
MDSCs, and (iii) CFTR partially overlaps with P. aeruginosa in
modulating neutrophilic MDSCs.
MATERIALS AND METHODS
Ethics Statement
All animal studies were reviewed and approved by the
Regierungspräsidium Tübingen, Tübingen, Germany (approval
ID: K4/12), and were carried out according to the guidelines of
the German law of protection of animal life.
Bacteria
P. aeruginosa wild type strains (PAO1) were used as published
previously by our group (Hector et al., 2015). Strains of the
culture collection were streaked on agar plates and incubated
at 37◦C overnight. Colonies were then inoculated into lysogeny
broth overnight. The next day, a 1:10 dilution in lysogeny broth
was performed and bacteria were cultured at 37◦C for 4 h. The
optical density was measured at 600 nm.
Mouse Models
Mice were bred at the animal facility of the Institute of
Pharmacology (Tübingen). C57Bl/6J or Cftr−/− [Cftrtm1Unc–
Tg(FABPCFTR)1Jaw/J] mice were used. Cftr−/− mice were
compared with age- and background strain-matched Cftr+/+
littermates. The mouse model of acute pulmonary P. aeruginosa
infection was performed as published by our group (Hector et al.,
2015). Mice were infected with 2 × 106 or 4 × 106 CFU of P.
aeruginosa (PAO1) utilizing previously established procedures
(Hector et al., 2015). Intranasal applications were carried out
under antagonizable anesthesia. Briefly, an inoculum of 2 × 106
and 4 × 106 CFU were administered intranasally (50µl/nostril).
After infection, body weight was monitored once a day over
1 week. For FACS analysis mice were sacrificed 16 h after
infection.
MDSC In vitro Generation
Bone marrow cells and splenocytes were isolated from Cftr+/+
and Cftr−/− mice and cultured in RPMI1640 (Merck Millipore)
with supplements, in detail 10% fetal bovine serum (Sigma),
100 U/ml Penicillin-Streptomycin (Merck Millipore) each,
2mM L-Glutamine (Merck Millipore), 10 mM HEPES (Merck
Millipore). MDSC generation was induced by addition of
40 ng/ml recombinant mouse GM-CSF (Biolegend) and 40 ng/ml
recombinant mouse IL-6 (Biolegend) as published by Marigo
et al. (2010). Cells were either fed with fresh media and cytokines
on d3 and d6 or collected and analyzed by flow cytometry at d3,
d6, and d10. For suppression assays cells were collected on d6.
MDSC Characterization, Isolation, and
Adoptive Transfer
Murine MDSCs were phenotypically characterized as described
previously (Rieber et al., 2015) by using CD11b, Ly6G
(neutrophilic MDSCs), and Ly6C (monocytic MDSCs) markers
followed by T-cell suppression assays to distinguish them
from non-suppressive neutrophilic or monocytic effector cells,
respectively. Flow cytometry was performed on a FACS
Calibur (BD). Murine MDSCs were isolated from different
organs/tissues/fluids as described previously (Rieber et al., 2015)
using MACS (MDSC isolation kit, Miltenyi). For adoptive
transfer experiments, CD11b+Ly6G+ neutrophilic MDSCs were
isolated from the bone marrow of healthy female C57Bl6/J
wildtype mice by MACS (MDSC isolation kit, Miltenyi Biotec,
Germany). Transfer was performed by transferring 8–10 × 106
neutrophilic MDSCs per animal into 8–12 weeks old female
C57Bl6/J wildtype mice via lateral tail vein injection. 24 h after
the neutrophilic MDSC transfer, mice were infected with P.
aeruginosa (PAO1) as described above.
T-Cell Suppression Assays
T-cell suppression assays were performed as described
previously (Rieber et al., 2015) using the CFSE method
according to the manufacturer’s protocol (Invitrogen). In
brief, CD11b+Ly6G+ neutrophilic MDSCs were isolated from
different organs/tissues/fluids by using MACS (MDSC isolation
kit, Miltenyi Biotec, Germany) and were co-cultured for 3
days (37◦C, 5% CO2) with MACS sorted CFSE stained CD4+
T-cells from splenocytes at MDSC: T-cell ratios 1:1, 1:2, 1:4,
and 1:8 in RPMI1640 with supplements as mentioned before.
The number of T-cells per well was kept at 105 and MDSCs
were added accordingly. T-cell proliferation was stimulated with
CD3/CD28-beads (mouse T-cell activation kit, Miltenyi Biotec,
Germany) and recombinant mouse IL-2 (50 U/ml, Biolegend).
CFSE-fluorescence intensity was analyzed by flow cytometry to
determine the percentage of polyclonally proliferated T-cells.
For the graphs the data was normalized to the proliferation of
the stimulated control T-cell proliferation (without addition of
MDSCs).
BALF
Bronchoalveolar lavage was extracted through the trachea with
2ml PBS. Living BAL cells were counted using trypan blue dye
exclusion. After erythrocyte lysis with ACK lysis solution, cells
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were incubated with an Fc receptor block (1µg/1× 106 cells; BD
Bioscience) to reduce nonspecific antibody binding.
Flow Cytometry
The panel of antibodies used to stain BALF, lung, spleen,
or bone marrow cells included CD11b (clone M1/70), Ly6G
(clone 1A8), and Ly6C (clone AL-21; all from BD Biosciences).
Flow cytometry was performed using BD FACS Calibur (BD
Bioscience), and data were analyzed with FlowJo software.
Statistics
Statistical analysis was done using GraphPad Prism 6.0 (Graph
Pad Software, La Jolla, CA, USA). Differences between the groups
were determined by Students’ t-test. A p < 0.05 was considered
to be significant.
RESULTS
Pseudomonas Infection Triggers
Neutrophilic MDSC Recruitment
We characterized the recruitment of neutrophilic and monocytic
MDSCs in response to acute P. aeruginosa airway infection in
different pulmonary (BALF, lung) and extra-pulmonary (spleen,
bone marrow) compartments in vivo (Figures 1A,D,E). To
this end, we analyzed MDSCs based on their (i) phenotypic
characteristics (Figure 1A) and their (ii) functional capacity
to dose-dependently suppress CD4+ T-cell proliferation
(Figures 1B,C). Utilizing these approaches we could demonstrate
that acute P. aeruginosa airway infection lead to an increase
of neutrophilic MDSCs in BALF and lung tissue by both
percentages as well as total cell numbers and lead to an increase
of MDSC percentages in the spleen (Figures 1A,D), whereas
the percentages or total cell numbers of neutrophilic MDSCs
decreased in the bone marrow compartment (Figure 1D).
Percentages of monocytic MDSCs remained unchanged in
BALF and bone marrow but increased in lung tissue had a
tendential increase in spleen, however to a far lesser extent
than neutrophilic MDSCs upon P. aeruginosa airway infection
(Figure 1E). Total monocytic MDSC numbers also increased
in lungs upon P. aeruginosa airway infection but remained
unchanged in spleen. Collectively, these studies indicate that P.
aeruginosa airway infection has a substantial effect on MDSCs in
vivo by triggering the recruitment of neutrophilic MDSCs into
the pulmonary compartment and increasing the percentage of
neutrophilic MDSCs in the spleen.
Pseudomonas Infection Enhances the
Suppressive Capacity of Neutrophilic
MDSCs
Next, we sought to dissect whether acute P. aeruginosa airway
infection not only recruits neutrophilic MDSCs, but also shapes
their functional characteristics in terms of suppressing T-
cell proliferation. For this purpose, we isolated neutrophilic
MDSCs from lungs, bone marrow, and spleens using MACS
technology and tested their capacity to suppress polyclonal
T-cell proliferation (Figure 2A). These studies demonstrated
that spleen-isolated neutrophilic MDSCs suppressed polyclonal
T-cell proliferation in a dose-dependent manner (Figure 2B).
This effect that was enhanced upon acute P. aeruginosa airway
infection, but depended on its magnitude and significance on the
origin of isolated neutrophilic MDSCs (bone marrow, spleens,
or lungs) and the MDSC-to-T-cell ratios applied (Figures 2B,C).
In general, neutrophilic MDSCs isolated from the lung had
the strongest suppressive capability, followed by neutrophilic
MDSCs isolated from bone marrow, while splenic neutrophilic
MDSCs showed the weakest suppression of polyclonal T-cell
proliferation (Figure 2C). When viewed in combination, these
experiments provide evidence that (i) neutrophilic MDSCs
in P. aeruginosa airway infection functionally dampen T-cell
proliferation and that (ii) P. aeruginosa airway infection topically
(pulmonary) and systemically enhances the suppressive capacity
of neutrophilic MDSCs.
Adoptive Transfer of Neutrophilic MDSCs
Has No Impact on Weight Loss and Weight
Recovery in Acute Pseudomonas Infection
To assess whether neutrophilicMDSCs bear therapeutic potential
in P. aeruginosa airway infection, we isolated neutrophilic
MDSCs from bone marrow by MACS technology, checked their
functionality ex vivo in T-cell suppression, adoptively transferred
the cells i.v. prior to acute P. aeruginosa airway infection and
monitored the impact of the adoptively transferred MDSCs
on weight loss and weight recovery after acute P. aeruginosa
airway infection (Figure 3). Two different infection doses were
assessed, 2 × 106 (Figure 3A) or 4 × 106 (Figure 3B) CFU.
These investigations demonstrated that the adoptive transfer of
neutrophilic MDSCs had no significant impact on weight loss
or weight recovery upon acute P. aeruginosa airway infection at
2 × 106 or 4 × 106 CFU (Figure 3). Both experimental groups
successfully cleared the pathogen, as we could not find any
residual CFU of P. aeruginosa at d5 (2 × 106 CFU) or d6 (4 ×
106 CFU) p.i. (data not shown).
CFTR Modulates Function, but Not
Recruitment or Generation of Neutrophilic
MDSCs
Since P. aeruginosa airway infections play a predominant role
in patients with CF, we sought to dissect the role of CFTR
in regulating the recruitment and functionality of neutrophilic
MDSCs in our experimental systems. For this purpose, we
first analyzed whether the absence of functional CFTR has
an impact on the recruitment of neutrophilic or monocytic
MDSCs into the airways or into non-pulmonary compartments
in vivo (Supplementary Figures 1, 2). Our data suggest that
Cftr deficiency has no significant effect on the recruitment of
neutrophilic MDSCs (Supplementary Figure 1) in any body
compartment in vivo, when analyzing Cftr−/− mice compared
to Cftr+/+ mice. Cftr deficiency also had no significant effect on
the recruitment of monocytic MDSCs (Supplementary Figure 2),
although the total numbers of monocytic MDSCs were decreased
in the bone marrow of Cftr−/− mice compared to Cftr+/+. Next,
we assessed whether the lack of CFTR has an effect on the in vitro
generation of neutrophilic MDSCs (Supplementary Figure 3).
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FIGURE 1 | Pseudomonas aeruginosa airway infection recruits MDSCs. (A) Neutrophilic (PMN–) MDSCs and monocytic (M–) MDSCs in BALF, lung, bone
marrow, and spleen were sequentially gated based on FSC/SSC, CD11b, Ly6G, and Ly6C. PMN-MDSCs were assessed as CD11b+Ly6G+Ly6Cintermediate,
M-MDSCs as CD11b+Ly6C+Ly6Glow. (B) Left panel: Gating strategy to assess CD4+ T-cell proliferation using CFSE staining and flow cytometry. CD4+ cells were
gated from the lymphocyte population in FSC/SSC and further gated for CD4+. T-cell proliferation was assessed based on the CFSE fluorescence of CD4+ T-cells.
Right panel: Representative histograms of co-cultured PMN-MDSCs isolated from BALF of PAO-1 infected mice and T-cells at ratios 1:1, 1:2, 1:4, and 1:8 as
indicated. (C) Ratio-dependent (suppressed) proliferation of CD4+ T-cells by co-culturing with neutrophilic MDSCs isolated from BALF of P. aeruginosa infected mice
is shown. The values are normalized to the proliferation of activated T-cells without addition of MDSCs (T-cells only) as indicated as proliferation index. (D) Percentages
(top row) and total amounts (bottom row) of neutrophilic MDSCs in BALF, lung, bone marrow, and spleen in acute P. aeruginosa infection compared to non-infected
control animals. Percentages of neutrophilic MDSCs (PMN-MDSCs) were acquired as % of CD11b+Ly6G+Ly6Cintermediate cells of viable cells (see A). Total cell
amounts were calculated from cell counts of single cell suspensions from isolated organs/tissues/fluids prior to FACS staining. **p < 0.01. (E) Percentages (top row)
and total amounts (bottom row) of monocytic MDSCs in BALF, lung, bone marrow, and spleen in acute P. aeruginosa infection compared to non-infected control
animals. Percentages of monocytic MDSCs (M-MDSCs) were acquired as % of CD11b+Ly6C+Ly6Glow cells of viable cells (see A). Total cell amounts were calculated
from cell counts of single cell suspensions from isolated organs/tissues/fluids prior to FACS staining. *p < 0.05; **p < 0.01; ***p < 0.001.
Consistent with the in vivo recruitment studies, these analyses
showed that the lack of CFTR had no effect on the generation of
neutrophilic MDSCs in vitro (Supplementary Figure 3). Finally,
we sought to determine whether the absence of CFTR has a
functional consequence for neutrophilic MDSCs in MDSC—
T-cell interaction assays. In contrast to the recruitment and
generation studies, these functional assays provided evidence that
in vitro generated Cftr−/− neutrophilic MDSCs were impaired
in suppressing T-cell proliferation compared to their Cftr+/+
counterpart cells, most strongly at a 1:4 and 1:8 MDSC: T-cell
ratios (Figure 4). In summary, these investigations demonstrated
that CFTR has no effect on the recruitment or generation of
MDSCs, but regulates, at least partially, MDSC-mediated T-cell
suppression.
DISCUSSION
MDSC generation and functionalities have been studied
thoroughly in several types of cancer (Filipazzi et al., 2012;
Bruchard et al., 2013; Wesolowski et al., 2013; Youn et al.,
2013; Diaz-Montero et al., 2014; Draghiciu et al., 2015; Marvel
and Gabrilovich, 2015), yet their regulation and functional
role in infectious disease conditions remained poorly defined.
Here we studied the role of MDSCs in the setting of
airway P. aeruginosa infection, which is highly relevant for
several human diseases, particularly CF, COPD, ventilation-
associated pneumonia and burn-related infections (Hogardt and
Heesemann, 2010; Jensen et al., 2010; Williams et al., 2010;
Pillarisetti et al., 2011).
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FIGURE 2 | Pseudomonas aeruginosa airway infection functionally modulates MDSCs. After P. aeruginosa airway infection CD11b+Ly6G+ neutrophilic
MDSCs were isolated from the lung, the bone marrow or the spleens and tested for their potential to suppress polyclonal T-cell proliferation. T-cell suppression assays
were performed as described previously (Rieber et al., 2015) using the CFSE method. In brief, isolated CD11b+Ly6G+ neutrophilic MDSCs were co-cultured for 3
days (37◦C, 5% CO2) with T-cells (CD4
+ splenocytes) at MDSC: T-cell ratios 1:1, 1:2, 1:4, and 1:8. T-cells were activated with CD3/CD28-beads and recombinant
mouse IL-2. CFSE-fluorescence intensity was analyzed by flow cytometry to determine polyclonal T-cell proliferation. (A) Strategy to assess the effect of acute P.
aeruginosa infection on MDSC-mediated T-cell suppression ex vivo. CD4+ T-cells were isolated by MACS from splenocytes of C57Bl6/J mice and stained with CFSE.
Ly6G+ cells were isolated from lungs, bone marrow, and spleens of infected and control C57Bl6/J mice. The isolated cells were co-cultured under T-cell proliferative
conditions (with CD3-CD28-coupled beads and rIL-2), collected after 3 days incubation at 37◦C 5% CO2, stained for CD4 and analyzed by flow cytometry.
(B) Representative histograms showing CFSE stained control CD4+ T-cell proliferation (top) and the suppressed proliferation caused by co-culture with isolated
neutrophilic MDSCs (see A) from spleens of PBS treated (left) and P. aeruginosa infected (right) C57Bl6/J mice with decreasing PMN-MDSC: T-cell ratios (1:1, 1:2, 1:4,
and 1:8). Each peak represents one cycle of cell division. (C) Graph showing the proliferation of T-cells under T-cell proliferative conditions when co-cultured with
suppressive neutrophilic MDSCs isolated from bone marrow, spleens and lungs of PBS treated or PAO1 infected C57BL6/J mice (see A). T-cell proliferation was
assessed based on CFSE fluorescence of CD4+ T-cells. (see Figure 1B). Shown are MDSC: T-cell ratios of 1:1 and 1:2. The values are normalized to the proliferation
of activated T-cells without addition of MDSCs (T-cells only), indicated as proliferation index. *p < 0.05.
These present studies build on previous findings from our
group demonstrate that (i) P. aeruginosa airway infections in
patients with CF were associated with increased percentages
of neutrophilic MDSCs in the peripheral blood and that (ii)
percentages of circulating neutrophilic MDSCs in P. aeruginosa
infected CF patients were positively correlated with the lung
function outcome (Rieber et al., 2013). Despite these intriguing
results, we so far do not have any mechanistic explanation(s)
how P. aeruginosa infection modulates MDSC recruitment and
function and why, unexpectedly, percentages of circulating
neutrophilic MDSCs were associated with a beneficial disease
outcome in patients with CF lung disease. To dissect this
host-pathogen interaction in vivo, we systematically investigated
the MDSCs in different immune and airway compartments
in a well-established model of acute P. aeruginosa infection
(Munder and Tummler, 2014). Our results here confirmed
and extended previous findings obtained from human CF
patients that P. aeruginosa infections induced MDSC subsets,
mainly being neutrophilic MDSCs. In vivo, acute P. aeruginosa
airway infections triggered neutrophilic MDSC recruitment
from the bone marrow into bronchoalveolar and pulmonary
compartments, where neutrophilic MDSCs were functionally
active in suppressing polyclonal effector T-cell responses.
Intriguingly, acute bacterial P. aeruginosa airway infections
not only recruited neutrophilic MDSCs to the infected airway
compartment, but also enhanced, at least partially, their T-cell
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FIGURE 3 | Adoptive transfer of neutrophilic MDSCs has no impact on weight loss and weight recovery in acute Pseudomonas infection. For adoptive
transfer experiments, CD11b+Ly6G+ neutrophilic MDSCs were isolated from the bone marrow of wildtype mice by MACS. Transfer was performed by transferring
8–10 × 106 neutrophilic MDSCs per animal into wildtype mice via lateral tail vein injection. 24 h after the neutrophilic MDSC transfer, mice were infected with doses of
2 × 106 (A) or 4 × 106 (B) CFU P. aeruginosa (PAO1) as described above in detail and weight loss was monitored.
FIGURE 4 | Role of CFTR in MDSC functionality. Neutrophilic MDSCs
were isolated from 6 days in vitro expanded splenocytes in supplemented
RPMI and GM-CSF and IL-6 of Cftr+/+ and Cftr−/− mice and tested for their
potential to suppress polyclonal T-cell proliferation. T-cell suppression assays
were performed as described previously (Rieber et al., 2015) using the CFSE
method. In brief, bone marrow isolated Cftr+/+ or Cftr−/− CD11b+Ly6G+
neutrophilic MDSCs were co-cultured for 3 days (37◦C, 5% CO2) with T-cells
(CD4+ splenocytes) at MDSC: T-cell ratios 1:1, 1:2, 1:4, and 1:8. T-cells were
activated with CD3/CD28-beads and recombinant mouse IL-2.
CFSE-fluorescence of CD4+ T-cells was analyzed by flow cytometry to
determine polyclonal T-cell proliferation. The values are normalized to the
proliferation of activated T-cells without addition of MDSCs (T-cells only),
indicated as proliferation index. **p < 0.01.
suppressive potential at a single cell level, surprisingly even at
sites distant from the primary site of airway infection, such as the
bone marrow. The underlying mechanisms for this phenomenon
remain to be solved in the future, but based on our previous
finding that neutrophilic MDSCs express Toll-like receptor 5
(TLR5) (Rieber et al., 2013) and its ligand flagellin is shed
from P. aeruginosa bacteria and can be found in the circulation
after P. aeruginosa airway infections (Hartl et al., unpublished
observation), we tempt to speculate that P. aeruginosa-derived
pathogen-associated molecular patterns (PAMPs), prototypically
flagellin, skew neutrophilic MDSCs systemically, including the
bone marrow compartment, to boost their immunosuppressive
functionalities, a hypothesis remaining to be tested in future
investigations. Overall, the precise in vivo kinetics, dynamics and
compartmentalizations in the complex setting of P. aeruginosa
infection remain to be deciphered in future in vivo studies.
Besides P. aeruginosa infection, we assessed the effect of Cftr
deficiency on the induction and function of neutrophilic MDSCs,
as it is pathophysiological the case for CF patients in vivo (Rieber
et al., 2013). Our in vivo model, however, failed to identify
a significant role for Cftr in MDSCs homeostasis, at least in
our experimental settings, since Cftr deficient mice displayed
the same amounts of neutrophilic MDSCs as their wildtype
littermates in BALF, lungs, spleens, and bone marrow, precluding
a major effect of Cftr. We also observed no difference on the
recruitment and accumulation of neutrophilic MDSCs in BALF
and lungs of Cftr deficient mice compared to wildtype littermates
upon acute pulmonary P. aeruginosa infection in vivo as well as
on neutrophilic MDSC generation in vitro.
In contrast to the neutrophilic MDSC-enhancing effect of
P. aeruginosa infections, Cftr deficiency, however, differentially
modulated the suppressive capability of in vitro-expanded
neutrophilic MDSCs. The underlying mechanism requires
further investigation, particularly given the complex role of Cftr
deficiency in driving a hyper-inflammatory micromilieu (Corvol
et al., 2003; Livraghi-Butrico et al., 2012) associated with MDSC
induction (Rieber et al., 2013; Ballbach et al., 2016). A possible
explanation for the diminished suppressive activity of Cftr−/−
neutrophilic MDSCs could be a scenario where MDSCs may
lose their suppressive function via inflammasome activity, as
discussed by Koehn et al. (2015).
Monocytic MDSC recruitment was also not affected by Cftr
deficiency, yet the total amount of cells in bone marrow of
Cftr−/− mice was diminished compared to Cftr+/+ littermates,
leading to a decreased net total amount of monocytic MDSCs
in bone marrow. In-depth characterization of this phenomenon
was, however, beyond the scope of this study, as the focus lied
mainly on neutrophilic MDSCs, the major CF-relevant MDSC
population (Rieber et al., 2013).
Inspired by previous findings from our group that
adoptive transfer of neutrophilic MDSCs was protective in
an invasive/systemic in vivo fungal infection model (Rieber
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et al., 2015), we tested the potential of adoptively transferred
neutrophilic MDSCs to affect the outcome of P. aeruginosa
infection in vivo. However, in our bacterial infection model, the
adoptive transfer of neutrophilicMDSCs did not affect the weight
loss and/or weight recovery of P. aeruginosa infected mice and
the bacterial clearance at d5 or d6 p.i.. Based on these findings,
we speculate that neutrophilic MDSCs have a more substantial
impact on invasive/systemic fungal infections compared to
compartmentalized P. aeruginosa airway infections in vivo.
The precise mechanisms underlying this difference remain to
be defined, but may relate to the fact that in invasive/systemic
fungal infections the protective effect of MDSCs was conferred
by MDSCs adoptively transferred i.v., the same route as fungal
pathogens were inoculated, whereas in contrast in the case of P.
aeruginosa airway infections, bacteria were inoculated topically
into the airways (intranasally) while MDSCs were adoptively
transferred i.v.. Consequently, in systemic fungal infections
both fungal pathogens and MDSCs were in close proximities,
whereas in the case of P. aeruginosa airway infections, MDSCs
would have to actively enter the airway compartment from the
circulation.
Our study has several limitations. (i) We were using an
acute P. aeruginosa infection model for our proof-of-concept
MDSC studies; yet a chronic infection/ colonization model,
which is much harder to standardize and read-out, would
resemble the situation of CF patients more closely; a task for
future investigations; (ii) our studies were unable to identify the
molecular mechanisms by which P. aeruginosa/P. aeruginosa-
derived factors enhance neutrophilic MDSC activity. Preliminary
studies failed to demonstrate significant involvements of
ROS and IL-10 (data not shown), issues requiring further
immunological and biochemical studies; (iii) lymphocytes
express Cftr, suggesting that Cftr in T-cells could affect the
functional outcome of MDSC-T-cell interactions in CF lung
disease, though preliminary data from our group showed no
significant impact of T-cellular Cftr on MDSC-T-cell studies
(data not shown); (iv) we observed in our suppression assays
that beyond CD4+ cells, also non-CD4+ cells in the fraction
of lymphocytes were proliferating. While we have no clear
explanation for this observation and its immunological relevance,
we speculate that these non-CD4+ T-cells may arise due to the
high stimulation trigger during our culture conditions. As the
population consistently appeared throughout the experiments,
we expect no substantial influence on the outcome of our
respective read-out studies; (v) data and knowledge on the
dynamics and kinetics of adoptively transferred MDSCs in vivo
are limited. Preliminary investigations showed that neutrophilic
MDSCs reach lungs of mice within 24 h after lateral tail vein
injection (data not shown). It is further known from previous
studies that adoptively transferred MDSCs can be recovered
from splenocytes 5 days post-injection (Koehn et al., 2015), yet
studies focusing on the kinetics and dynamics of adoptively
transferred MDSCs in the pulmonary compartment are lacking
to the best of our current knowledge; (vi) Our adoptive transfer
study lacks further in-depth read-outs, such as lung inflammation
parameters, amounts, and characteristics of parenchymal T-cells
or kinetics on pathogen clearance. Since our MDSC adoptive
transfer studies did not reveal any impact of MDSCs on
morbidity, we did restrict our read-outs to theminimum. Further
studies are required to dissect the temporal and spatial in vivo
kinetics and dynamics of MDSCs and T-cells in the infected
pulmonary compartment.
Collectively, when viewed in combination, this study
demonstrates that acute P. aeruginosa airway infection recruits
and functionally modulates neutrophilic myeloid-derived
suppressor cells and thereby defines a mechanism by which P.
aeruginosa undermines host immunity in vivo by modulating
neutrophilic MDSCs.
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Infections with P. aeruginosa, an opportunistic gram-negative
bacterium, represent a major cause of morbidity and mortality
in patients with CF lung disease. Upon airway infection, P.
aeruginosa activates the innate immune system. However, in
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CF. The underlying immune mechanisms remained poorly
understood. Myeloid-derived suppressor cells (MDSCs) are anti-
inflammatory innate immune cells that potently suppress T-
cellular immune responses. We showed in a previous study
that neutrophilic MDSCs accumulate in patients with CF
infected with P. aeruginosa and correlate with lung function in
those patients. Here, we demonstrate that P. aeruginosa airway
infection recruits and functionally activates neutrophilic MDSCs
and thereby define a mechanism by which P. aeruginosa airway
infection undermines host immunity by modulating neutrophilic
MDSCs in vivo.
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